All In MedTech

Device Trial Radar · NCT05818150

GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

Multicenter, PrOspective, Randomized, Controlled Trial Comparing GenIcular Artery EmbOlization Using Embosphere Microspheres to Corticosteroid iNjections for the Treatment of Symptomatic Knee Osteoarthritis: MOTION Study

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

52

Actual

Start

Jan 16, 2024

Primary completion

May 28, 2026

Study completion May 28, 2026

Sponsor

Lead sponsor
Merit Medical Systems, Inc.Public (MMSI)
Sponsor type
Industry
First posted
Apr 18, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This multicenter, prospective, interventional trial is designed to assess the outcome of subjects with symptomatic knee osteoarthritis (OA) that are randomized to treatment with either genicular artery embolization (GAE) using Embosphere Microspheres or steroid injection over a period of 24 months.

Conditions

  • Knee Osteoarthritis

Interventions

  • Embosphere MicrospheresDevice

    Embolic Agent: Embosphere Microspheres

  • Corticosteroid injectionDrug

    Corticosteroid injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Efficacy EndpointTime frame: 6 months

1 more outcomes with a free account

Locations

17 sites in 4 countries. Site status is shown where the registry gives one.

  • Georgetown University Medical Center

    Washington D.C., District of Columbia

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.